Timothy K. Andrews serves as Executive at Sienna Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Timothy K. Andrews has executed 4 insider transactions totaling $225.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 6, 2019 involved receiving (via award) 50,000 shares valued at $0.
Timothy K. Andrews currently holds 145,558 shares of Sienna Biopharmaceuticals, Inc. (SNNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy K. Andrews has been a net buyer of SNNA stock. They have purchased $225.0K and sold $0 worth of shares.
Timothy K. Andrews's most recent insider trade was on Aug 6, 2019, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.76 |
| Discretionary |
| Jan 1, 2019 | SNNA | $0 | Award | 45,000 | $N/A | Discretionary |
| Aug 1, 2017 | SNNA | $225.0K | Purchase | 15,000 | $15.00 | Discretionary |